Ophthalmic Drugs Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Ophthalmic Drugs Market

1.1. Definition and Scope

1.1.1. Definition of Ophthalmic Drugs

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Ophthalmic Drugs Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Ophthalmic Drugs Market By Class

1.2.3. Ophthalmic Drugs Market By Disease

1.2.4. Ophthalmic Drugs Market By Dosage Form

1.2.5. Ophthalmic Drugs Market By Product Type

1.2.6. Ophthalmic Drugs Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Ophthalmic Drugs Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Ophthalmic Drugs Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Ophthalmic Drugs Market By Class

5.1. Introduction

5.2. Ophthalmic Drugs Revenue By Class

5.2.1. Ophthalmic Drugs Revenue (USD Billion) and Forecast, By Class, 2020-2032

5.2.2. Antiallergy

5.2.2.1. Antiallergy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents

5.2.3.1. Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Anti-inflammatory

5.2.4.1. Anti-inflammatory Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4.2. Nonsteroidal Drugs

5.2.4.2.1. Nonsteroidal Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4.3. Steroidal Drugs

5.2.4.3.1. Steroidal Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Antiglaucoma

5.2.5.1. Antiglaucoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Others

5.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Ophthalmic Drugs Market By Disease

6.1. Introduction

6.2. Ophthalmic Drugs Revenue By Disease

6.2.1. Ophthalmic Drugs Revenue (USD Billion) and Forecast, By Disease, 2020-2032

6.2.2. Dry Eye

6.2.2.1. Dry Eye Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.2. Gels

6.2.2.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.3. Eye Solutions

6.2.2.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.4. Capsules & Tablets

6.2.2.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.5. Eye Drops

6.2.2.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.6. Ointments

6.2.2.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Allergies

6.2.3.1. Allergies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Gels

6.2.4.1.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4.2. Eye Solutions

6.2.4.2.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4.3. Capsules & Tablets

6.2.4.3.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4.4. Eye Drops

6.2.4.4.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4.5. Ointments

6.2.4.5.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Glaucoma

6.2.5.1. Glaucoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5.2. Gels

6.2.5.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5.3. Eye Solutions

6.2.5.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5.4. Capsules & Tablets

6.2.5.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5.5. Eye Drops

6.2.5.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5.6. Ointments

6.2.5.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Inflammation/Infection

6.2.6.1. Inflammation/Infection Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6.2. Gels

6.2.6.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6.3. Eye Solutions

6.2.6.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6.4. Capsules & Tablets

6.2.6.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6.5. Eye Drops

6.2.6.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6.6. Ointments

6.2.6.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Retinal Disorders

6.2.7.1. Retinal Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7.2. Gels

6.2.7.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7.3. Eye Solutions

6.2.7.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7.4. Capsules & Tablets

6.2.7.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7.5. Eye Drops

6.2.7.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7.6. Ointments

6.2.7.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8. Uveitis

6.2.8.1. Uveitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8.2. Gels

6.2.8.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8.3. Eye Solutions

6.2.8.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8.4. Capsules & Tablets

6.2.8.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8.5. Eye Drops

6.2.8.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8.6. Ointments

6.2.8.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.9. Others

6.2.9.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Ophthalmic Drugs Market By Dosage Form

7.1. Introduction

7.2. Ophthalmic Drugs Revenue By Dosage Form

7.2.1. Ophthalmic Drugs Revenue (USD Billion) and Forecast, By Dosage Form, 2020-2032

7.2.2. Gels

7.2.2.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Eye Solutions

7.2.3.1. Eye Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Capsules & Tablets

7.2.4.1. Capsules & Tablets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Eye Drops

7.2.5.1. Eye Drops Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Ointments

7.2.6.1. Ointments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Ophthalmic Drugs Market By Product Type

8.1. Introduction

8.2. Ophthalmic Drugs Revenue By Product Type

8.2.1. Ophthalmic Drugs Revenue (USD Billion) and Forecast, By Product Type, 2020-2032

8.2.2. Prescription Drugs

8.2.2.1. Prescription Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. OTC Drugs

8.2.3.1. OTC Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Ophthalmic Drugs Market By Country 

9.1. North America Ophthalmic Drugs Market Overview

9.2. U.S.

9.2.1. U.S. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

9.2.2. U.S. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

9.2.3. U.S. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

9.2.4. U.S. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.3. Canada

9.3.1. Canada Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

9.3.2. Canada Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

9.3.3. Canada Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

9.3.4. Canada Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Ophthalmic Drugs Market By Country

10.1. Europe Ophthalmic Drugs Market Overview

10.2. U.K.

10.2.1. U.K. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

10.2.2. U.K. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

10.2.3. U.K. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

10.2.4. U.K. Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.3. Germany

10.3.1. Germany Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

10.3.2. Germany Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

10.3.3. Germany Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

10.3.4. Germany Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.4. France

10.4.1. France Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

10.4.2. France Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

10.4.3. France Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

10.4.4. France Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.5. Spain

10.5.1. Spain Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

10.5.2. Spain Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

10.5.3. Spain Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

10.5.4. Spain Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

10.6.2. Rest of Europe Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

10.6.3. Rest of Europe Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

10.6.4. Rest of Europe Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Ophthalmic Drugs Market By Country

11.1. Asia Pacific Ophthalmic Drugs Market Overview

11.2. China

11.2.1. China Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.2.2. China Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.2.3. China Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.2.4. China Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.3. Japan

11.3.1. Japan Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.3.2. Japan Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.3.3. Japan Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.3.4. Japan Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.4. India

11.4.1. India Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.4.2. India Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.4.3. India Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.4.4. India Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.5. Australia

11.5.1. Australia Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.5.2. Australia Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.5.3. Australia Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.5.4. Australia Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.6. South Korea

11.6.1. South Korea Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.6.2. South Korea Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.6.3. South Korea Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.6.4. South Korea Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

11.7.2. Rest of Asia-Pacific Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

11.7.3. Rest of Asia-Pacific Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

11.7.4. Rest of Asia-Pacific Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Ophthalmic Drugs Market By Country

12.1. Latin America Ophthalmic Drugs Market Overview

12.2. Brazil

12.2.1. Brazil Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

12.2.2. Brazil Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

12.2.3. Brazil Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

12.2.4. Brazil Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.3. Mexico

12.3.1. Mexico Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

12.3.2. Mexico Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

12.3.3. Mexico Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

12.3.4. Mexico Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

12.4.2. Rest of Latin America Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

12.4.3. Rest of Latin America Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

12.4.4. Rest of Latin America Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Ophthalmic Drugs Market By Country 

13.1. Middle East & Africa Ophthalmic Drugs Market Overview

13.2. GCC

13.2.1. GCC Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

13.2.2. GCC Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

13.2.3. GCC Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

13.2.4. GCC Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

13.3. South Africa

13.3.1. South Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

13.3.2. South Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

13.3.3. South Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

13.3.4. South Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Class, 2020-2032

13.4.2. Rest of Middle East & Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Disease, 2020-2032

13.4.3. Rest of Middle East & Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Dosage Form, 2020-2032

13.4.4. Rest of Middle East & Africa Ophthalmic Drugs Revenue (USD Billion) and Forecast By Product Type, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Ophthalmic Drugs Market

14.1. Ophthalmic Drugs Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Ophthalmic Drugs Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. AbbVie Inc.

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. AbbVie Inc. 2022 Ophthalmic Drugs Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Alcon

15.3. Bausch Health Companies Inc.

15.4. Bayer AG

15.5. Coherus Biosciences, Inc.

15.6. F. Hoffmann-La Roche Ltd (Genentech, Inc.)

15.7. Merck & Co., Inc.

15.8. Nicox

15.9. Novartis AG

15.10. Pfizer Inc.

15.11. Regeneron Pharmaceuticals Inc.